The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes

Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus. Methods...

Full description

Saved in:
Bibliographic Details
Published inDiabetic medicine Vol. 30; no. 2; pp. e41 - e50
Main Authors Kadoglou, N. P. E., Fotiadis, G., Kapelouzou, A., Kostakis, A., Liapis, C. D., Vrabas, I. S.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus. Methods One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self‐controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60–75% of maximum heart rate); (3) a resistance training group (60–80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima‐media thickness measurements were obtained at baseline and at the end of the study, after 6 months. Results At baseline, there were non‐significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high‐sensitivity C‐reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within‐ and between‐group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima‐media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. Conclusions In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima‐media thickness progression.
AbstractList Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus. Methods One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self‐controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60–75% of maximum heart rate); (3) a resistance training group (60–80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima‐media thickness measurements were obtained at baseline and at the end of the study, after 6 months. Results At baseline, there were non‐significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high‐sensitivity C‐reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within‐ and between‐group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima‐media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. Conclusions In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima‐media thickness progression.
Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima-media thickness in patients with Type 2 diabetes mellitus. Methods One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self-controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60-75% of maximum heart rate); (3) a resistance training group (60-80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima-media thickness measurements were obtained at baseline and at the end of the study, after 6 months. Results At baseline, there were non-significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high-sensitivity C-reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within- and between-group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima-media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. Conclusions In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima-media thickness progression. [PUBLICATION ABSTRACT]
Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima-media thickness in patients with Type 2 diabetes mellitus. One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self-controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60-75% of maximum heart rate); (3) a resistance training group (60-80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA(1c) levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima-media thickness measurements were obtained at baseline and at the end of the study, after 6 months. At baseline, there were non-significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high-sensitivity C-reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within- and between-group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima-media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima-media thickness progression.
Abstract Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus. Methods One hundred patients with Type 2 diabetes were equivalently ( n  = 25) randomized into four groups: (1) a control group with patients encouraged to perform self‐controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60–75% of maximum heart rate); (3) a resistance training group (60–80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA 1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima‐media thickness measurements were obtained at baseline and at the end of the study, after 6 months. Results At baseline, there were non‐significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group ( P  < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups ( P  < 0.05). Moreover, high‐sensitivity C‐reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups ( P  < 0.05). Within‐ and between‐group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima‐media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P  < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. Conclusions In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima‐media thickness progression.
OBJECTIVEAdipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima-media thickness in patients with Type 2 diabetes mellitus.METHODSOne hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self-controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60-75% of maximum heart rate); (3) a resistance training group (60-80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA(1c) levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima-media thickness measurements were obtained at baseline and at the end of the study, after 6 months.RESULTSAt baseline, there were non-significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high-sensitivity C-reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within- and between-group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima-media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake.CONCLUSIONSIn subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima-media thickness progression.
Author Kapelouzou, A.
Liapis, C. D.
Vrabas, I. S.
Fotiadis, G.
Kadoglou, N. P. E.
Kostakis, A.
Author_xml – sequence: 1
  givenname: N. P. E.
  surname: Kadoglou
  fullname: Kadoglou, N. P. E.
  email: nikoskad@yahoo.com
  organization: Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki
– sequence: 2
  givenname: G.
  surname: Fotiadis
  fullname: Fotiadis, G.
  organization: First Department of Internal Medicine, 'Hippokratio' General Hospital of Thessaloniki, Thessaloniki
– sequence: 3
  givenname: A.
  surname: Kapelouzou
  fullname: Kapelouzou, A.
  organization: Center of Experimental Surgery, Biomedical Research FoundationAcademy of Athens
– sequence: 4
  givenname: A.
  surname: Kostakis
  fullname: Kostakis, A.
  organization: Center of Experimental Surgery, Biomedical Research FoundationAcademy of Athens
– sequence: 5
  givenname: C. D.
  surname: Liapis
  fullname: Liapis, C. D.
  organization: Department of Vascular Surgery, University of Athens, Athens, Greece
– sequence: 6
  givenname: I. S.
  surname: Vrabas
  fullname: Vrabas, I. S.
  organization: Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23078531$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFu1DAURS1URKeFBT-ALLGBRVrbsZN4iUoZkFpAYoCl5dgvjEsSD7ZHbf6GJd_Bl-GQtgskvPCT7HOv7tM9QgejHwGhp5Sc0HxO7QAnlBEhHqAV5RUvBJf0AK1IzVlRkpoeoqMYrwihTJbyETpk-bERJV2hX5stYOu6DgKMyeke6zwKN3a9HgadfJgw5F-TIvYdhhsIxkXAg7e6d8lBzAKL0xZcwDpGb5xOzo_42qUtBh36CRsdfHIW60wFH00_3y7iXfDfAsQ4427EuyzMGeIi3Uw7-P2T5Wy6hQTxMXrY6T7Ck9t5jD6_Od-cvS0uPqzfnb26KEwpqSiElLyzhFS04rypQBvgtOksM7StWsOYFgAcam7aqqlEQ0sKxAIXkljNG14eoxeLb073Yw8xqcFFA32vR_D7qCiry7ohjSwz-vwf9Mrvw5jTzRSta8nq2fDlQpm8dQzQqV1wgw6TokTN9alcn_pbX2af3Tru2wHsPXnXVwZOF-Da9TD930m9vjy_sywWhYsJbu4VOnxXVd5EqK_v12pNv3wUl58aJcs_EcO5EA
CODEN DIMEEV
CitedBy_id crossref_primary_10_1016_j_numecd_2021_02_030
crossref_primary_10_1186_s13102_024_00915_4
crossref_primary_10_1002_jcp_28420
crossref_primary_10_1007_s40279_015_0379_7
crossref_primary_10_1080_17446651_2018_1416290
crossref_primary_10_3390_healthcare11040594
crossref_primary_10_1007_s11154_021_09657_x
crossref_primary_10_1007_s40279_013_0128_8
crossref_primary_10_1123_japa_2019_0150
crossref_primary_10_1016_j_clinthera_2017_05_001
crossref_primary_10_1136_bjsports_2016_095999
crossref_primary_10_14814_phy2_15674
crossref_primary_10_23736_S0022_4707_23_15263_7
crossref_primary_10_3390_jfmk7020048
crossref_primary_10_3389_fendo_2023_1216962
crossref_primary_10_1515_tjb_2020_0014
crossref_primary_10_1111_bph_12399
crossref_primary_10_1016_j_cca_2013_09_001
crossref_primary_10_1016_j_dsx_2016_06_017
crossref_primary_10_1016_j_physbeh_2022_113888
crossref_primary_10_5812_asjsm_57690
crossref_primary_10_3390_antiox12081488
crossref_primary_10_1007_s00424_022_02702_x
crossref_primary_10_1113_EP087005
crossref_primary_10_2147_DMSO_S438344
crossref_primary_10_1016_j_apunts_2015_05_001
crossref_primary_10_1016_j_cyto_2023_156157
crossref_primary_10_1002_jcsm_12926
crossref_primary_10_7717_peerj_17525
crossref_primary_10_4239_wjd_v14_i5_565
crossref_primary_10_1016_j_cyto_2020_155364
crossref_primary_10_1590_s1980_6574201800020006
crossref_primary_10_1002_tsm2_294
crossref_primary_10_1515_tjb_2021_0023
crossref_primary_10_1007_s00421_014_3016_5
crossref_primary_10_1371_journal_pone_0296815
crossref_primary_10_1016_j_archger_2024_105530
crossref_primary_10_1016_j_gene_2018_04_003
crossref_primary_10_1186_s43162_023_00247_8
crossref_primary_10_1007_s11892_017_0927_7
crossref_primary_10_1016_j_jdiacomp_2019_107469
crossref_primary_10_1186_s40798_019_0194_z
crossref_primary_10_4093_dmj_2023_0112
crossref_primary_10_1038_s41598_020_67004_7
crossref_primary_10_1186_s12905_019_0722_5
crossref_primary_10_2478_prilozi_2021_0010
crossref_primary_10_3390_ijerph20031783
crossref_primary_10_1097_PHM_0000000000001002
crossref_primary_10_3389_fphys_2023_1252052
crossref_primary_10_1007_s00125_014_3303_z
crossref_primary_10_1152_japplphysiol_00247_2020
crossref_primary_10_1016_j_jshs_2022_11_003
crossref_primary_10_1097_MD_0000000000031861
crossref_primary_10_1007_s11332_018_0462_1
crossref_primary_10_1139_apnm_2015_0693
crossref_primary_10_1155_2017_8523728
crossref_primary_10_1007_s13105_017_0602_0
crossref_primary_10_1007_s42000_019_00157_x
crossref_primary_10_1016_j_exger_2019_01_003
crossref_primary_10_1007_s11332_015_0225_1
crossref_primary_10_1111_obr_13564
crossref_primary_10_1161_JAHA_114_000828
crossref_primary_10_3390_healthcare11030440
crossref_primary_10_3390_ph16101396
crossref_primary_10_1111_obr_13007
crossref_primary_10_3389_fendo_2022_820002
crossref_primary_10_4236_health_2017_912118
crossref_primary_10_1038_ijo_2013_158
crossref_primary_10_1177_15598276231180541
crossref_primary_10_3390_healthcare10061098
crossref_primary_10_1016_j_exger_2023_112310
crossref_primary_10_1016_j_bjpt_2017_06_004
crossref_primary_10_1111_sms_12495
crossref_primary_10_3390_ijerph20032189
crossref_primary_10_3389_fphys_2019_00656
crossref_primary_10_1007_s11332_013_0157_6
crossref_primary_10_1113_EP089371
crossref_primary_10_1007_s13410_015_0329_9
crossref_primary_10_1089_met_2013_0054
crossref_primary_10_3390_biomedicines11051290
crossref_primary_10_4093_dmj_2022_0007
crossref_primary_10_1007_s40279_014_0226_2
crossref_primary_10_1186_s12933_016_0336_2
crossref_primary_10_1016_j_scispo_2022_11_003
crossref_primary_10_2147_DMSO_S247351
crossref_primary_10_14814_phy2_14823
crossref_primary_10_17795_ajnpp_34440
crossref_primary_10_3390_nu15061539
crossref_primary_10_1016_j_jsams_2024_03_007
crossref_primary_10_5763_kjsm_2020_38_3_155
crossref_primary_10_1177_1479164115588548
crossref_primary_10_3390_nu11102432
crossref_primary_10_3390_ijerph192214928
crossref_primary_10_1123_jpah_2022_0372
Cites_doi 10.1016/j.metabol.2006.03.017
10.1016/B978-0-12-385061-4.00008-8
10.1111/j.1463-1326.2008.00872.x
10.1111/j.1365-2265.2011.04135.x
10.2337/dc12-s011
10.1016/j.metabol.2011.01.006
10.2337/db07-1045
10.1155/2012/941868
10.1007/s00125-010-2042-z
10.1111/j.1467-789X.2010.00776.x
10.2165/11531380-000000000-00000
10.1002/dmrr.1201
10.1016/j.regpep.2011.05.008
10.1016/j.cca.2010.09.012
10.1249/MSS.0b013e31824526cc
10.1097/HJH.0b013e328344da76
10.2337/diacare.24.1.117
10.1517/13543784.17.3.327
10.1016/j.ejim.2011.10.020
10.1097/HJR.0b013e3282efaf50
10.1007/BF03165767
10.1001/jama.2010.1710
10.2217/bmm.10.79
10.1016/j.trsl.2010.01.004
10.1055/s-0029-1237360
10.1016/j.amjcard.2009.03.027
10.1007/s11695-009-9955-y
10.1016/j.coph.2005.10.006
10.1016/j.ejvs.2007.08.022
10.1016/j.numecd.2009.04.015
ContentType Journal Article
Copyright 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK
2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Diabetic Medicine © 2013 Diabetes UK
Copyright_xml – notice: 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK
– notice: 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
– notice: Diabetic Medicine © 2013 Diabetes UK
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1111/dme.12055
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
Genetics Abstracts
MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Nursing
EISSN 1464-5491
EndPage e50
ExternalDocumentID 2870911751
10_1111_dme_12055
23078531
DME12055
ark_67375_WNG_G1VP5MS8_9
Genre article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
29F
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RWI
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XV2
YFH
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3915-5994fd006164486eace418fd2c1b6bc22a5ee4e74cb68658131e0de4590da4843
IEDL.DBID DR2
ISSN 0742-3071
IngestDate Fri Aug 16 22:25:03 EDT 2024
Thu Oct 10 19:41:05 EDT 2024
Fri Aug 23 00:54:51 EDT 2024
Sat Sep 28 08:07:43 EDT 2024
Sat Aug 24 00:49:48 EDT 2024
Wed Oct 30 09:51:02 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3915-5994fd006164486eace418fd2c1b6bc22a5ee4e74cb68658131e0de4590da4843
Notes ArticleID:DME12055
istex:3CDB4A62F045211003637E99525092CEDBD93E48
ark:/67375/WNG-G1VP5MS8-9
Clinical Trials Registry No; NCT 00636766
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
PMID 23078531
PQID 1271779274
PQPubID 1006515
PageCount 10
ParticipantIDs proquest_miscellaneous_1273780893
proquest_journals_1271779274
crossref_primary_10_1111_dme_12055
pubmed_primary_23078531
wiley_primary_10_1111_dme_12055_DME12055
istex_primary_ark_67375_WNG_G1VP5MS8_9
PublicationCentury 2000
PublicationDate 2013-02
February 2013
2013-Feb
2013-02-00
20130201
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 2013-02
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Diabetic medicine
PublicationTitleAlternate Diabet. Med
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008; 17: 327-333.
Kadoglou NP, Iliadis F, Liapis CD. Exercise and carotid atherosclerosis. Eur J Vasc Endovasc Surg 2008; 35: 264-272.
Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome, and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 2011; 27: 515-527.
Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 2009; 19: 1574-1580.
Przewlocka-Kosmala M, Kotwica T, Mysiak A, Kosmala W. Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction. J Hypertens 2011; 29: 971-979.
Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 2010; 20: 608-617.
Swift DL, Johannsen NM, Earnest CP, Blair SN, Church TS. Effect of exercise training modality on C-reactive protein in type 2 diabetes. Med Sci Sports Exerc 2012; 44: 1028-1034.
Jorge ML, de Oliveira VN, Resende NM, Paraiso LF, Calixto A, Diniz AL et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 2011; 60: 1244-1252.
American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35: S11-S63.
Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Tsanikidis H, Vitta I et al. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2010; 118: 75-80.
Friebe D, Neef M, Kratzsch J, Erbs S, Dittrich K, Garten A et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011; 54: 1200-1211.
Cederberg H, Koivisto VM, Jokelainen J, Surcel HM, Keinänen-Kiukaanniemi S, Rajala U. Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention. Clin Endocrinol (Oxf) 2012; 76: 39-45.
Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD et al. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007; 14: 837-843.
Carpéné C, Dray C, Attané C, Valet P, Portillo MP, Churruca I et al. Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 2007; 63: 359-373.
Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. J Am Med Assoc 2010; 304: 2253-2262.
Arsenault BJ, Cartier A, Côté M, Lemieux I, Tremblay A, Bouchard C et al. Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women. Am J Cardiol 2009; 104: 240-246.
Srtasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010; 40: 397-415.
Wing RR, Goldstein MG, Acton KJ, Birch LL, Jakicic JM, Sallis JF et al. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 2001; 24: 117-123.
García EA, Korbonits M. Ghrelin and cardiovascular health. Curr Opin Pharmacol 2006; 6: 142-147.
Kadoglou NP, Lampropoulos S, Kapelouzou A, Gkontopoulos A, Theofilogiannakos EK, Fotiadis G et al. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease-Kozani Study. Transl Res 2010; 155: 238-246.
Xu A, Wang Y, Lam KS, Vanhoutte PM. Vascular actions of adipokines molecular mechanisms and therapeutic implications. Adv Pharmacol 2010; 60: 229-255.
Kadoglou NP, Avgerinos ED, Liapis CD. An update on markers of carotid atherosclerosis in patients with Type 2 diabetes. Biomark Med 2010; 4: 601-609.
Golbidi S, Badran M, Laher I. Antioxidant and anti-inflammatory effects of exercise in diabetic patients. Exp Diabetes Res 2012; 2012: 941868.
Brema I, Hatunic M, Finucane F, Burns N, Nolan JJ, Haider D et al. Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab 2008; 10: 600-602.
Adams CE, Greenway FL, Brantley PJ. Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance. Obes Rev 2011; 12: e211-e218.
Kadoglou NP, Vrabas IS, Kapelouzou A, Lampropoulos S, Sailer N, Kostakis A et al. Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk. Regul Pept 2011; 170: 57-61.
Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, Theofilogiannakos EK, Kottas G et al. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta 2011; 412: 48-52.
Kadoglou NP, Vrabas IS, Kapelouzou A, Angelopoulou N. The association of physical activity with novel adipokines in patients with type 2 diabetes. Eur J Intern Med 2012; 23: 137-142.
Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377.
Kim SH, Lee SJ, Kang ES, Kang S, Hur KY, Lee HJ et al. Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism 2006; 55: 1053-1059.
2011; 412
2012; 2012
2010; 304
2006; 55
2011; 60
2008; 17
2006; 6
2011; 54
2008; 57
2008; 35
2008; 10
2011; 170
2011; 12
2012; 35
2001; 24
2012; 76
2010; 40
2007; 14
2010; 60
2010; 20
2010; 118
2010; 155
2007; 63
2011; 27
2009; 19
2012; 23
2010; 4
2012; 44
2011; 29
2009; 104
e_1_2_5_27_1
e_1_2_5_28_1
e_1_2_5_25_1
e_1_2_5_26_1
e_1_2_5_23_1
e_1_2_5_24_1
e_1_2_5_21_1
e_1_2_5_22_1
e_1_2_5_29_1
e_1_2_5_20_1
e_1_2_5_15_1
e_1_2_5_14_1
e_1_2_5_17_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_8_1
e_1_2_5_11_1
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_5_1
e_1_2_5_12_1
e_1_2_5_4_1
e_1_2_5_3_1
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
e_1_2_5_30_1
e_1_2_5_31_1
References_xml – volume: 76
  start-page: 39
  year: 2012
  end-page: 45
  article-title: Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention
  publication-title: Clin Endocrinol (Oxf)
– volume: 155
  start-page: 238
  year: 2010
  end-page: 246
  article-title: Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease—Kozani Study
  publication-title: Transl Res
– volume: 40
  start-page: 397
  year: 2010
  end-page: 415
  article-title: Resistance training in the treatment of the metabolic syndrome: a systematic review and meta‐analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism
  publication-title: Sports Med
– volume: 4
  start-page: 601
  year: 2010
  end-page: 609
  article-title: An update on markers of carotid atherosclerosis in patients with Type 2 diabetes
  publication-title: Biomark Med
– volume: 14
  start-page: 837
  year: 2007
  end-page: 843
  article-title: The anti‐inflammatory effects of exercise training in patients with type 2 diabetes mellitus
  publication-title: Eur J Cardiovasc Prev Rehabil
– volume: 104
  start-page: 240
  year: 2009
  end-page: 246
  article-title: Body composition, cardiorespiratory fitness, and low‐grade inflammation in middle‐aged men and women
  publication-title: Am J Cardiol
– volume: 35
  start-page: S11
  year: 2012
  end-page: S63
  article-title: Standards of medical care in diabetes—2012
  publication-title: Diabetes Care
– volume: 304
  start-page: 2253
  year: 2010
  end-page: 2262
  article-title: Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial
  publication-title: J Am Med Assoc
– volume: 118
  start-page: 75
  year: 2010
  end-page: 80
  article-title: Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes
  publication-title: Exp Clin Endocrinol Diabetes
– volume: 19
  start-page: 1574
  year: 2009
  end-page: 1580
  article-title: Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus
  publication-title: Obes Surg
– volume: 23
  start-page: 137
  year: 2012
  end-page: 142
  article-title: The association of physical activity with novel adipokines in patients with type 2 diabetes
  publication-title: Eur J Intern Med
– volume: 20
  start-page: 608
  year: 2010
  end-page: 617
  article-title: Anti‐inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss
  publication-title: Nutr Metab Cardiovasc Dis
– volume: 63
  start-page: 359
  year: 2007
  end-page: 373
  article-title: Expanding role for the apelin/APJ system in physiopathology
  publication-title: J Physiol Biochem
– volume: 54
  start-page: 1200
  year: 2011
  end-page: 1211
  article-title: Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre‐B cell colony (PBEF)/visfatin linking obesity and inflammation in humans
  publication-title: Diabetologia
– volume: 57
  start-page: 372
  year: 2008
  end-page: 377
  article-title: Serum vaspin concentrations in human obesity and type 2 diabetes
  publication-title: Diabetes
– volume: 12
  start-page: e211
  year: 2011
  end-page: e218
  article-title: Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance
  publication-title: Obes Rev
– volume: 60
  start-page: 229
  year: 2010
  end-page: 255
  article-title: Vascular actions of adipokines molecular mechanisms and therapeutic implications
  publication-title: Adv Pharmacol
– volume: 412
  start-page: 48
  year: 2011
  end-page: 52
  article-title: Serum levels of vaspin and visfatin in patients with coronary artery disease—Kozani study
  publication-title: Clin Chim Acta
– volume: 44
  start-page: 1028
  year: 2012
  end-page: 1034
  article-title: Effect of exercise training modality on C‐reactive protein in type 2 diabetes
  publication-title: Med Sci Sports Exerc
– volume: 60
  start-page: 1244
  year: 2011
  end-page: 1252
  article-title: The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus
  publication-title: Metabolism
– volume: 29
  start-page: 971
  year: 2011
  end-page: 979
  article-title: Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction
  publication-title: J Hypertens
– volume: 55
  start-page: 1053
  year: 2006
  end-page: 1059
  article-title: Effects of lifestyle modification on metabolic parameters and carotid intima‐media thickness in patients with type 2 diabetes mellitus
  publication-title: Metabolism
– volume: 27
  start-page: 515
  year: 2011
  end-page: 527
  article-title: Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome, and cardiovascular diseases: a meta‐analysis and systemic review
  publication-title: Diabetes Metab Res Rev
– volume: 24
  start-page: 117
  year: 2001
  end-page: 123
  article-title: Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity
  publication-title: Diabetes Care
– volume: 10
  start-page: 600
  year: 2008
  end-page: 602
  article-title: Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus
  publication-title: Diabetes Obes Metab
– volume: 35
  start-page: 264
  year: 2008
  end-page: 272
  article-title: Exercise and carotid atherosclerosis
  publication-title: Eur J Vasc Endovasc Surg
– volume: 170
  start-page: 57
  year: 2011
  end-page: 61
  article-title: Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk
  publication-title: Regul Pept
– volume: 17
  start-page: 327
  year: 2008
  end-page: 333
  article-title: Vaspin: a novel serpin with insulin‐sensitizing effects
  publication-title: Expert Opin Investig Drugs
– volume: 6
  start-page: 142
  year: 2006
  end-page: 147
  article-title: Ghrelin and cardiovascular health
  publication-title: Curr Opin Pharmacol
– volume: 2012
  start-page: 941868
  year: 2012
  article-title: Antioxidant and anti‐inflammatory effects of exercise in diabetic patients
  publication-title: Exp Diabetes Res
– ident: e_1_2_5_30_1
  doi: 10.1016/j.metabol.2006.03.017
– ident: e_1_2_5_6_1
  doi: 10.1016/B978-0-12-385061-4.00008-8
– ident: e_1_2_5_21_1
  doi: 10.1111/j.1463-1326.2008.00872.x
– ident: e_1_2_5_28_1
  doi: 10.1111/j.1365-2265.2011.04135.x
– ident: e_1_2_5_2_1
  doi: 10.2337/dc12-s011
– ident: e_1_2_5_20_1
  doi: 10.1016/j.metabol.2011.01.006
– ident: e_1_2_5_24_1
  doi: 10.2337/db07-1045
– ident: e_1_2_5_19_1
  doi: 10.1155/2012/941868
– ident: e_1_2_5_22_1
  doi: 10.1007/s00125-010-2042-z
– ident: e_1_2_5_27_1
  doi: 10.1111/j.1467-789X.2010.00776.x
– ident: e_1_2_5_3_1
  doi: 10.2165/11531380-000000000-00000
– ident: e_1_2_5_7_1
  doi: 10.1002/dmrr.1201
– ident: e_1_2_5_26_1
  doi: 10.1016/j.regpep.2011.05.008
– ident: e_1_2_5_12_1
  doi: 10.1016/j.cca.2010.09.012
– ident: e_1_2_5_18_1
  doi: 10.1249/MSS.0b013e31824526cc
– ident: e_1_2_5_23_1
  doi: 10.1097/HJH.0b013e328344da76
– ident: e_1_2_5_31_1
  doi: 10.2337/diacare.24.1.117
– ident: e_1_2_5_11_1
  doi: 10.1517/13543784.17.3.327
– ident: e_1_2_5_16_1
  doi: 10.1016/j.ejim.2011.10.020
– ident: e_1_2_5_5_1
  doi: 10.1097/HJR.0b013e3282efaf50
– ident: e_1_2_5_9_1
  doi: 10.1007/BF03165767
– ident: e_1_2_5_4_1
  doi: 10.1001/jama.2010.1710
– ident: e_1_2_5_14_1
  doi: 10.2217/bmm.10.79
– ident: e_1_2_5_10_1
  doi: 10.1016/j.trsl.2010.01.004
– ident: e_1_2_5_15_1
  doi: 10.1055/s-0029-1237360
– ident: e_1_2_5_25_1
  doi: 10.1016/j.amjcard.2009.03.027
– ident: e_1_2_5_8_1
  doi: 10.1007/s11695-009-9955-y
– ident: e_1_2_5_13_1
  doi: 10.1016/j.coph.2005.10.006
– ident: e_1_2_5_29_1
  doi: 10.1016/j.ejvs.2007.08.022
– ident: e_1_2_5_17_1
  doi: 10.1016/j.numecd.2009.04.015
SSID ssj0012939
Score 2.4369082
Snippet Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different...
Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise...
Abstract Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of...
Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different...
OBJECTIVEAdipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage e41
SubjectTerms Adipokines - metabolism
Analysis of Variance
Anti-Inflammatory Agents - metabolism
Apelin
Blood Glucose - metabolism
Cardiovascular disease
Carotid Artery Diseases - blood
Carotid Artery Diseases - physiopathology
Carotid Artery Diseases - prevention & control
Carotid Intima-Media Thickness
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - physiopathology
Diabetes Mellitus, Type 2 - therapy
Diabetic Angiopathies - blood
Diabetic Angiopathies - physiopathology
Diabetic Angiopathies - therapy
Diet
Disease Progression
Exercise
Fasting
Female
Ghrelin - metabolism
Glycated Hemoglobin A - metabolism
Humans
Insulin Resistance
Intercellular Signaling Peptides and Proteins - metabolism
Male
Middle Aged
Nicotinamide Phosphoribosyltransferase - metabolism
Physical fitness
Resistance Training
Risk Factors
Serpins - metabolism
Title The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes
URI https://api.istex.fr/ark:/67375/WNG-G1VP5MS8-9/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.12055
https://www.ncbi.nlm.nih.gov/pubmed/23078531
https://www.proquest.com/docview/1271779274
https://search.proquest.com/docview/1273780893
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NitRAEC6WFcWLq6uuWVcpRcRLhnSmO0njSdw_hFlEXd2DEDrpDgzrJLKZAfHkI_gInn0MH8UnsarzoysK4mUYmO6kp_NV-qvq6q8AHmSsYe4yE5pCuVBmiQu1ky6MpikzXqejig8nz46Sw2P57ESdrMHj4SxMpw8xBtzYMvz7mg3cFO0vRm4XbiLiSPEBczFNOZ1r98UoHcXLmO4kOGOOr4heVYizeMae59aiCzytH_5ENM_zVr_w7G_A22HIXb7J6WS1LCblx9_UHP_zP12FKz0hxScdgq7Bmqs34dKs33LfhIt9POE6fCVI4VBQhV4M75Ceyvz7p88EUsLVwu_XY58ggk2FQzknXDSW6T455dTFot-cQPMTGMjRYHSstYxcR2g5t-iZadPSmOhz3qJPJOtERHBeY68H23Zd2Zv-9iXGIZJ8A4739149PQz7Ug9hyQr1odJaVpb5FPuLCa0GToqssnEpiqQo49goRxBKZVkkGZEmMRUusk4qHVkjMzm9Cet1U7tbgMRZtTHSpK4S0uhSF1aUTsuokpmKjA3g_vDQ8_edokc-eEI0_7mf_wAeejiMLczZKafApSp_c3SQH4jXz9XsZZbrAHYGvOS99bd0CXKSU00OfwD3xp_JbnkzxtSuWfk2BNqI6GIAWx3Oxptxcj7RKBHAI4-Wv48z353t-S_b_970NlyOfU0PzsnZgfXl2crdIWa1LO56E_oBH-cipQ
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VVlAu_BQogQIGIcQlqzixk1jigujPAs0KQQu9oMiJHWlVNkHdXQlx4hF4BM48Bo_CkzDj_EARSIjLaqW1E6_zjf3NePINwP2UNMxtqn1dSOuLNLa-ssL6QZQQ47UqqOjl5GwSjw_FsyN5tAKP-ndhWn2IIeBGluHWazJwCkj_YuVmZkc8DKQ8A2to7hEVbth-OYhH0UamWhHOkCIsvNMVojyeoeup3WiNJvbDn6jmaebqtp7di_C2H3SbcXI8Wi6KUfnxNz3H__1Xl-BCx0nZ4xZEl2HF1htwLutO3TfgbBdSuAJfEVWsr6mCa8M7hg9m-v3TZ8QpQmvmjuxZlyPCmor1FZ3YrDHE-NEvxy6GufMJpn9ig1FAmFmSW2ZUSmgxNcyR02aOY8LP6Zy5XLJWR4RNa9ZJws7bruRQf_sSsj6YfBUOd3cOnoz9rtqDX5JIvS-VEpUhSkUuY4wbghU8rUxY8iIuyjDU0iKKElEWcYq8iUfcBsYKqQKjRSqia7BaN7W9Dgxpq9Ja6MRWXGhVqsLw0ioRVCKVgTYe3Oufev6-FfXIe2cI5z938-_BA4eHoYU-OaYsuETmbyZ7-R5__UJmr9JcebDVAybvFoA5XgL95EShz-_B3eFnNF06j9G1bZauTZSkATJGDzZboA03o_x8ZFLcg4cOLn8fZ76d7bgvN_696R1YHx9k-_n-08nzm3A-dCU-KEVnC1YXJ0t7C4nWorjt7OkHFpomvQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwEB2VVlR94VIuDRQwCCFesoqzdhKLJ0S7LZddVUChD0iWEzvSqmxSdXclxBOfwCfwzGfwKXwJM84FikBCvEQrxU68zpn4zHhyBuB-RhrmLjOhyaULRZa4UDnhwmiYEuN1Kirp4-TxJNk_FM-O5NEKPOq-hWn0IfqAG1mGf1-TgZ_Y8hcjtzM34HEk5TlYEwkyX2JEL3vtKFrHVKPBGVOAhbeyQpTG03c9sxit0bx--BPTPEtc_cozugjvujE3CSfHg-UiHxQff5Nz_M8_dQkutIyUPW4gdBlWXLUJ6-N2z30TzrcBhSvwFTHFuooq-GZ4z_CxTL9_-owoRWDN_IY9azNEWF2yrp4Tm9WW-D565djFMr87wcxPZDAKBzNHYsuMCgktppZ5alrPcUx4nM6ZzyRrVETYtGKtIOy86Uru9LcvMetCyVfhcLT7-sl-2NZ6CAuSqA-lUqK0RKjIYUxwOXCCZ6WNC54neRHHRjrEUCqKPMmQNfEhd5F1QqrIGpGJ4TVYrerKbQFD0qqMESZ1JRdGFSq3vHBKRKXIZGRsAPe6h65PGkkP3blCOP_az38ADzwc-hbm9Jhy4FKp30729B5_cyDHrzKtAtju8KJb85_jJdBLThV6_AHc7U-j4dJujKlcvfRthmkWIV8M4HqDs_5mlJ2PPIoH8NCj5e_j1DvjXf_jxr83vQPrBzsj_eLp5PlN2Ih9fQ_Kz9mG1cXp0t1ClrXIb3tr-gGTOSVs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+differential+anti%E2%80%90inflammatory+effects+of+exercise+modalities+and+their+association+with+early+carotid+atherosclerosis+progression+in+patients+with+Type%C2%A02+diabetes&rft.jtitle=Diabetic+medicine&rft.au=Kadoglou%2C+N.+P.+E.&rft.au=Fotiadis%2C+G.&rft.au=Kapelouzou%2C+A.&rft.au=Kostakis%2C+A.&rft.date=2013-02-01&rft.issn=0742-3071&rft.eissn=1464-5491&rft.volume=30&rft.issue=2&rft_id=info:doi/10.1111%2Fdme.12055&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_dme_12055
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon